Category Archives: Myocardial Infarction

Many finns stand now for too long the heart symptoms. This shows heart hospitals, and doctors are concerned about the phenomenon. Continue reading →

Global Cardiac Marker Analyzer Market: Overview The global cardiac marker analyzer market is anticipated to rise at a noteworthy pace in the years ahead. The high-value applications of cardiac marker analyzer accounts for the high growth prospects of the cardiac marker analyzer market Continue reading →

Caution in prescribing off-label medicines, and deferring coronary angiography in stable patients with COVID-19 and suspected myocardial infarction, are two of the key recommendations issued in the consensus statement on cardiovascular disease (CVD) and COVID-19. The Heart Foundation has summarised the advice to cardiac health services in a consensus statement endorsed by the Heart Foundation, Cardiac Society of Australia and New Zealand (CSANZ), and the High Blood Pressure Research Council of Australia. This statement is the first of its kind to be released in Australia and summarises the available data on COVID-19 and cardiovascular disease, said co-author, Heart Foundation Chief Medical Adviser, cardiologist Professor Garry Jennings. Continue reading →

Executive Summary Introduction/Background By itemizing charges for each individual service and procedure performed during an episode of care, Medicare fee-for-service (FFS) encourages greater utilization of provider services and, thus, higher healthcare costs. To facilitate phasing out FFS for hospitals, the Social Security Amendments of 1983 established the Prospective Payment System (PPS) for Medicare.[1] The goal of the PPS was to alter hospital behavior under the FFS structure by incentivizing more cost-efficient care management. This law consolidated charges for care received in a hospital, paid by Part A, into one lump sum through the Diagnosis-Related Group (DRG) classification systema departure from the separate, itemized charges under FFS Continue reading →

Type 2 diabetes mellitus (T2DM) and stroke are two different diseases, but have many aspects in common. Aspirin is recommended as an initial treatment for the secondary prevention of recurrent ischemic stroke in patients with T2DM. However, clopidogrel is an oral antiplatelet drug that might be another choice in case of aspirin intolerance. Continue reading →

The guidelines allow for the addition of short-term clopidogrel to an oral anticoagulant (OAC) in patients with an established OAC indication, such as atrial fibrillation (AF), who undergo transcatheter aortic valve replacement (TAVR). But does the extra antithrombotic protection come with safety issues? Continue reading →

Anatomic severity of diseasebut not severity of ischemiapredicted the risk of death or MI over 4 years of follow-up in the ISCHEMIA trial, a new analysis shows. However, an invasive strategy as compared with medical therapy offered no benefit regardless of disease severity based on level of ischemia or extent of coronary disease, according to ISCHEMIA investigators. Continue reading →

William R Hiatt More bleeding with background clopidogrel, even if not severe by adjudication, may be associated with broad consequences, including discontinuation of therapies. In the absence of clear benefit, clopidogrel exposure along with aspirin and rivaroxaban should be minimised or avoided to reduce this risk, concluded William R Hiatt (University of Colorado Anschutz School of Medicine, Aurora, USA), presenting a subgroup analysis of the VOYAGER-PAD trial during the American College of Cardiology/World Congress of Cardiologys virtual scientific sessions (ACC.20/WCC Virtual)originally scheduled to take place on 2830 March in Chicago, USA Continue reading →

CYBERSPACE Online learning rises to the next level starting March 28 with the ambitious, pioneering response from the American College of Cardiology (ACC) to the cancellation of its annual scientific sessions live meeting forced by the COVID-19 pandemic, uncharted territory in most every way. The sessions are going online in three simultaneous real-time streams and videos and slides on demand, archived for 30-day access. And it will be free to literally anyone with internet and a computer, tablet, or smartphone Continue reading →

BACKGROUND: The 2013 American College of Cardiology/American Heart Association cholesterol guideline recommends high-intensity statin (HIS) in patients with atherosclerotic cardiovascular disease, but little is known about the efficacy and safety of HIS in Asian ethnicity. We assessed the effects of HIS in Taiwanese with acutemyocardial infarction(AMI). Consecutive patients admitted for new AMI between January 2010 and December 2013 without prior statin use were enrolled from the Taiwan National Health Insurance Research Database Continue reading →